Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies the safety and effects of acetylsalicylic acid
(aspirin) taken continuously or intermittently on gene expression in the nasal tissue of
current smokers. Smokers are at increased risk of developing lung cancer. Acetylsalicylic
acid may be useful in preventing lung cancer.